Another Indian drugmaker expanding in Nigeria

India's Nestor Pharmaceuticals says it has acquired land in Nigeria for a second plant there. Construction is slated to begin in November of next year, when it will build a plant to make liquid, syrups, soft capsules and beta-lactum products, reports Express Pharma. It will invest about 25 crore rupees ($5 million). The company last year opened its first manufacturing facility in Nigeria. Nestor is not the only Indian drugmaker expanding in Nigeria: Ranbaxy Laboratories announced a few weeks ago that it would build there, too. Rahul Sehgal, Nestor president, says the company also is planning a manufacturing plant in Rajasthan, India, that will be built to FDA standards. Plans are for that to begin in 2014. Story | More

Suggested Articles

Cambrex has completed installation of multiple continuous flow reactor platforms at its facility in High Point, North Carolina.

Australia’s Mayne Pharma has opened its $80 million oral solid-dose manufacturing facility in Greenville, North Carolina.

GE is launching its prefab line of drug manufacturing units that will help biopharma companies produce viral vector-based vaccines.